Collaboration on Data and Computational Sciences Announces Next Round of Projects to Advance Cancer Breakthroughs
The Oden Institute for Computational Engineering and Sciences (Oden Institute), The University of Texas MD Anderson Cancer Center (MD Anderson) and Texas Advanced Computing Center (TACC) have announced the second round of projects to be funded through their 2021-2022 cooperative research and educational program in Oncological Data and Computational Sciences.
The strategic initiative between the three institutions was...
Combination targeted therapy provides durable remission for patients with chronic lymphocytic leukemia
A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic...
ARCHIVED: Pancreas cancer liquid biopsy flows from blood-borne packets of tumor genes
MD Anderson scientists do next-generation analysis of complete tumor genomes from exosomes
MD Anderson News Release 12/17/2015
ARCHIVED: New York businessman, philanthropist gives $30 million to cancer research
Andrew Sabin Fellowship Program aims to advance MD Anderson’s goal to end cancer
MD Anderson News Release 11/16/2015
Andy Sabin, of East Hampton, N.Y., has committed $30 million — the philanthropist’s largest grant to date — to support research at The University of Texas MD Anderson Cancer Center.
The gift, through the Andrew Sabin Family Foundation, establishes the Andrew Sabin Family Fellowship Program...
ARCHIVED: Helping preschoolers deploy ‘superpowers’ against sunburn
Ray and the Sunbeatables™ debut through CATCH; arise from MD Anderson research
MD Anderson News Release 08/12/2015
Five...
ARCHIVED: Poor survival among colorectal cancer patients tied to biomarker CSN6
MD Anderson News Release 08/10/2015
A protein called CSN6 has been found to be correlated with poor survival among patients...
ARCHIVED: Sentinel lymph node mapping identifies positive lymph nodes in women with high-risk endometrial cancer, MD Anderson study finds
Research offers promise for less invasive staging tool, future management of disease
MD Anderson News Release 03/31/2015
...
ARCHIVED: Anderson Algorithm increases surgical success with advanced ovarian cancer
Moon Shots Program effort boosts complete resection rates over 86 percent
MD Anderson News Release 02/27/2015
A surgical...
ARCHIVED: “Father of Tamoxifen” to Join MD Anderson
Breast Cancer Research Pioneer V. Craig Jordan, Ph.D., Developer Of Several Cancer-Fighting Drugs, Brings His Translational Research Expertise...
ARCHIVED: UT MD Anderson Scientists Discover Secret Life of Chromatin
DNA/histone combination, a destination for cell signals, also talks to other proteins
MD Anderson News Release 08/30/2011...